相关实验视频

Updated: Jan 9, 2026

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

胆癌2026年:现状,未得到满足的需求和优先事项

Jesus M Banales^1,2,3,4, Pedro M Rodrigues^5,6,7, Silvia Affò⁸

¹Department of Liver and Gastrointestinal Diseases, Biogipuzkoa Health Research Institute - Donostia University Hospital, University of the Basque Country (UPV/EHU), San Sebastian, Spain. jesusmaria.banalesasurmendi@bio-gipuzkoa.eus.

Nature reviews. Gastroenterology & hepatology

|December 10, 2025

概括

胆管癌 (CCA) 是一种罕见的胆管癌,发病率不断增加,预后不佳. 这份共识声明回顾了CCA理解,管理和有前途的新疗法方面的最新进展.

科学领域:

在瘤学瘤学.
胃肠病学胃肠病学
病理学病理学病理学

背景情况:

胆管癌 (CCA) 是一种异质的胆管癌,其全球发病率和死亡率正在增加.
常常是晚期出现的CCA,导致预后不佳,治疗选择有限,主要是缓解性治疗.
虽然存在风险因素,但大多数CCA病例是零星的,突出显示了对其起源的理解上的差距.

研究的目的:

提供关于胆管癌 (CCA) 研究的最新进展的批判性概述.
突出CCA的关键方面:病原性,临床管理和新兴的治疗策略.
为CCA建立共识建议和未来的研究重点.

主要方法:

国际共识声明由欧洲胆管癌研究网络认可.
审查CCA病原发生和临床管理的最新进展.
德尔菲小组调查问卷,涉及国际专家制定建议.

主要成果:

在理解驱动胆管癌发生的分子机制方面仍然存在重大差距.
目前的治疗方法提供了适度的生存改善,并且通常是息的.
合作努力的重点是确定新的生物标志物和治疗点,以获得更有效的治疗方法.

结论:

更好地了解CCA的病原发生是开发有效治疗方法的关键.
需要新的生物标志物和治疗点来改善患者的治疗结果.
达成共识的建议和定义的研究重点对于推进CCA护理至关重要.

更多相关视频

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb

Published on: January 17, 2025

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Chronic Pancreatitis II: Collaborative Care

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment: